The official blog of the Lung Institute.

Product Review: AlerSense Air Quality System

23 May 2016
| Under Product Reviews, Resources | Posted by
| 1 Comment
Product Review: AlerSense Air Quality System

For many people with chronic lung diseases, environmental triggers can worsen their symptoms. While there’s not much you can do about outdoor air quality or allergens, you can monitor your home’s indoor air quality. To help you know what’s available, we’ve looked into a new product that could be beneficial to you. Here’s what you need to know about the AlerSense Air Quality System.

What is the AlerSense Air Quality System?

According to AlerSense, their AlerSense Air Quality System is an in-home unit combined with a mobile app, which delivers accurate environmental readings. These readings warn asthma and allergy sufferers to the indoor air’s build-up of particle and toxin levels. The technology used by AlerSense is the same technology used in industrial-grade air quality monitoring.

Because chronic lung diseases–such as asthma and COPD–are affected by airborne allergens, knowing your indoor air quality could help prevent a flare-up.

How does the AlerSense Air Quality System work?

The AlerSense system silently monitors your home environment 24/7, screening, measuring and reporting airborne contaminants, toxins, humidity and temperature. It sends alerts to a mobile app on your phone if and when any changes to air quality occurs. Now, you can monitor the indoor air quality of your home anywhere and anytime.

Because you’ll be able to keep track of the air quality, you can alert your family when airborne contaminants like pollen, animal dander, mold and toxins increase. The cloud based algorithms of AlerSense search for patterns that could lead to allergy or respiratory attacks. As the AlerSense system tracks the air quality patterns in your home, it will become smarter, making its alerts more refined to fit your needs.

What does AlerSense detect?

AlerSense screens for common triggers for people with allergies, asthma and other respiratory conditions. These triggers include:

  • Dust
  • Pollen
  • Mold Spores
  • Chemicals or Toxins in the Air
  • Airborne Dust Mite Allergens

AlerSense’s system has several on-board sensors. The system can screen for coarse particles, such as molds, and fine particles, such as dust mite allergens and dense smoke. It can also screen for volatile organic compounds (VOCs) that are found in traditional household cleaners. The system screens for carbon dioxide (CO2), which can cause drowsiness and headaches. Many people describe high levels of CO2 as a stuffy atmosphere in a room. In addition, AlerSense measures the temperature and humidity indoors.

AlerSense is also testing the next version of AlerSense, which would identify and differentiate specific particles. In addition, they are testing an airborne pathogen detector which could detect certain airborne viruses and bacteria.

Product Review: AlerSense Air Quality SystemKeep in mind that Alersense is an air quality monitoring system, and it does not purify or clean the air in your home. To improve your home’s air quality based on the data AlerSense sends to you, it’s suggested to consider air purifiers and to talk with your doctor about which purifiers he or she recommends.

If you’re interested in learning more or purchasing AlerSense, you can learn more here.

What else can I do to improve my lung health?

Along with monitoring the air quality in your home with the AlerSense Air Quality System, there are other ways to improve your lung health and reduce your flare-up risks. You and your doctor can work on a plan which could include exercises, a healthy diet and lifestyle modifications. For many people with COPD and other chronic lung diseases, cellular therapy has helped them regain their quality of life and improved their lung health. We are happy to answer your questions, so feel free to contact us at 888-745-6697 today.

* Every patient is given a Patient Satisfaction Survey shortly after treatment. Responses to the 11-question survey are aggregated to determine patient satisfaction with the delivery of treatment.

^ Quality of Life Survey data measured the patient’s self-assessed quality of life and measurable quality of improvement at three months of COPD patients.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.